Our results also provide a potential proposal for targeted therapy based on tetraspanin proteins to treat HCC, and further mechanism investigations are needed to reveal a more detailed mechanism of action for NET-1 protein regulation of HCC. The gene discussed is NET1; the disease is hepatocellular carcinoma.